Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Rangering i aksjer #42765
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$150.00
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Poniard Pharmaceuticals, Inc. (PARD)

Kategori

Pris PARD pris med markedsverdi på B
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
PARD
$0.0001
Markedsverdi av Poniard Pharmaceuticals, Inc.(PARD)
Markedsverdi: $150.00
Per August 2026 har Poniard Pharmaceuticals, Inc. en markedsverdi på $150.00. Dette gjør Poniard Pharmaceuticals, Inc. til det 42765th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Poniard Pharmaceuticals, Inc. fra 1988 til 2026
PARD sammenlignet med topp 5 mest populære stocks
Pris på PARD Eiendel B Markedsverdi for B Resultater
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$3,617,326 $150.00
$5.426T +3,617,325,682,222.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,951,277 $150.00
$4.427T +2,951,277,314,540.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,759,300 $150.00
$4.139T +2,759,299,687,403.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,437,362 $150.00
$3.656T +2,437,362,459,384.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$1,923,764 $150.00
$2.886T +1,923,763,906,900.00%